申请人:Pierre Fabre Medicament
公开号:US05254554A1
公开(公告)日:1993-10-19
The application discloses pharmacologically-active 3-hydroxy-1-phenyl-1,4-dihydro-4-oxopyridazine compounds, derivatives thereof, a method for the preparation thereof, pharmaceutical compositions thereof, and a method of treating anxiety and other physiological abnormalities therewith.
该申请公开了具有药理活性的3-羟基-1-苯基-1,4-二氢-4-氧基吡啶嗪化合物及其衍生物,其制备方法,药物组合物以及利用其治疗焦虑和其他生理异常的方法。